Morningstar on Thursday upgraded banking software and technology company Temenos (TEMN.SW) to buy from hold and increased its price target to 81 francs from 77 francs.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
Craig Hallum Downgrades BioLife Solutions to Hold From Buy
Maxim Downgrades BioLife Solutions to Hold From Buy
UDR (UDR) has an average rating of Hold and mean price target of $41.95, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $39.55, Change: $-0.02, Percent Change: -0.05%